International Clinical Trial: The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07740109) titled 'The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease' on July 22.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Tabriz University of Medical Sciences

Condition: Nonalcoholic Fatty Liver Disease Nonalcoholic Fatty Liver Disease (NAFLD) MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease MASLD NAFLD Metabolic Dysfunction-Associated Steatotic Li...